LIAISON® Fertility Panel

Fertility
Fertility
Fully automated solution
for diagnosis of fertility and hormonal monitoring
FOR OUTSIDE THE US ONLY
FOR OUTSIDE THE US ONLY
Fertility
Most couples achieve pregnancy within the first six months of trying. Overall, after 12 months of frequent
unprotected intercourse, about 90 percent of couples will become pregnant. The majority of couples will eventually
conceive, with or without treatment.
If getting pregnant has been a challenge for you and your partner, you’re not alone. In a range of 10 to 15 percent
of couples in the United States are infertile (www.mayoclinic.org).
In some cases, an infertile woman may have irregular or absent menstrual periods. An infertile man may have
signs of hormonal problems, such as changes in hair growth, sexual function, reduced sexual desire, or problems
with ejaculation. He may also have small testicles or a swelling in the scrotum.
CLINICAL INDICATION
Monitoring response to ovulation induciton therapy
Impotency
Hirsutism
Female infertility workup
Male infertility workup
?
reduced
spermiogram
hormonal
disorders
tubal occlusion
vas deference
occlusion
premature
ovarian failure
endometriosis
genetic diseases
genetic diseases
malignant
diseases
congenital factors
adenoids
fibroids
azoospermia
malignant
diseases
35.5%
nd
ty a
rtili
pat
hic
infe
15%
Idio
ale
in
Ma
le
and
Fem
ty
rtili
Fem
ale
Infe
ty
infe
rtili
www.iss.it
fert
of the National Health Service in Italy,
the causes of infertility
are distributed in this way
Ma
le
ility
According to the ISS - Institution
oth
er
35.4%
14.2%
Infertility may be due to a single cause in either you or your partner, or a combination of factors that may prevent
a pregnancy from occurring or continuing. Fortunately, there are many safe and effective therapies for overcoming
infertility. Moreover, the need of a full evaluation to understand the clinical situation through specific laboratory
testing: a variety of diagnostic assays should be carried out.
LH, FSH, prolactin, estradiol, progesterone, hCG, testosterone and dehydroepiandrosterone-sulfate
(DHEA-S) tests represent the majority of fertility and pregnancy immunoassays.
TEST INCLUDED
Estradiol, LH
Testosterone, Prolactin
LH, FSH, Testosterone, DHEA-S, Prolactin
LH, FSH, Estradiol, Progesterone, Prolactin, DHEA-S
LH, FSH, Prolactin, Testosterone
Fertility
?
LIAISON® Fertility line is a fully automated solution for reliable assessment of the
reproducutive disorders.
It includes the following assays:
LIAISON® Prolactin xt - code 312171
LIAISON® XL HCG - code 312321
LIAISON® Estradiol II Gen - code 310680
LIAISON® FSH - code 312251
LIAISON® Progesterone II Gen - code 310690
LIAISON® LH - code 312201
LIAISON® Testosterone - code 310410
LIAISON® Prolactin - code 312151
LIAISON® DHEA-S - code 310430
Peptide hormones traceable to the
available WHO reference standards
Steroid hormones calibrated to the LC-MS
Excellent sensitivity and precision
No high-dose hook effect
Ready to use reagents
Fully automated, high throughput assays
Open use integral stability 4 weeks
AVAILABLE ON
SYSTEMS
M0850004309 10/14
LIAISON® HCG - code 312311
Product availability subject to required regulatory approval
DiaSorin S.p.A.
Via Crescentino
13040 Saluggia (VC) - Italy
Tel. +39.0161.487526
Fax: +39.0161.487670
www.diasorin.com
E-mail: [email protected]